Historique
Livre
Drug policy and the public good
Auteur(s) :
BABOR, T. F. ;
CAULKINS, J. P. ;
EDWARDS, G. ;
FISCHER, B. ;
FOXCROFT, D. R. ;
HUMPHREYS, K. ;
OBOT, I. S. ;
REHM, J. ;
REUTER, P. ;
ROOM, R. ;
ROSSOW, I. ;
STRANG, J.
Année :
2010
Page(s) :
388 p.
Langue(s) :
Anglais
Éditeur(s) :
Oxford - New York : Oxford University Press
ISBN :
978-0-19-955712-7
Refs biblio. :
53 p.
Domaine :
Autres substances / Other substances ; Drogues illicites / Illicit drugs
Discipline :
SAN (Santé publique / Public health)
Thésaurus géographique
INTERNATIONAL
Thésaurus mots-clés
DONNEE PROBANTE
;
EPIDEMIOLOGIE
;
PRODUIT ILLICITE
;
MARCHE DE LA DROGUE
;
POLITIQUE
;
EFFICACITE
;
INTERVENTION
;
PREVENTION
;
POSSESSION DE DROGUE
;
DEPENALISATION
;
PSYCHOTROPES
;
LEGISLATION
;
DISPOSITIF DE SOIN
;
SANTE PUBLIQUE
;
PROGRAMME
;
REDUCTION DES RISQUES ET DES DOMMAGES
Note de contenu :
TABLE OF CONTENTS:
* Part 1 - Introduction
1. Framing the issues
2. Matters of substance
* Part 2 - Drug epidemiology and drug markets
3. The international dimensions of drug use
4. Harms associated with illicit drug use
5. Illegal markets: the economics of drug distribution and social harm
6. The legal market: prescription and diversion of psychopharmaceuticals
* Part 3 - The evidence base for drug policy: research on strategies and interventions
7. Strategies and interventions to reduce drug use and related harm: section overview
8. Preventing illicit drug use by young people
9. Health and social services for drug users
10. Supply control
11. Criminalization and decriminalization of drug use or possession
12. Prescription regimes and other measures to control misuse of psychopharmaceuticals
* Part 4 - Drug policy and system issues at the national and international levels
13. Drug policy and control at the international level
14. The variety of national drug policies
15. Health and social services for drug users: systems issues
* Part 5 - Synthesis and conclusions
16. Summary and conclusions
Appendix A
* Part 1 - Introduction
1. Framing the issues
2. Matters of substance
* Part 2 - Drug epidemiology and drug markets
3. The international dimensions of drug use
4. Harms associated with illicit drug use
5. Illegal markets: the economics of drug distribution and social harm
6. The legal market: prescription and diversion of psychopharmaceuticals
* Part 3 - The evidence base for drug policy: research on strategies and interventions
7. Strategies and interventions to reduce drug use and related harm: section overview
8. Preventing illicit drug use by young people
9. Health and social services for drug users
10. Supply control
11. Criminalization and decriminalization of drug use or possession
12. Prescription regimes and other measures to control misuse of psychopharmaceuticals
* Part 4 - Drug policy and system issues at the national and international levels
13. Drug policy and control at the international level
14. The variety of national drug policies
15. Health and social services for drug users: systems issues
* Part 5 - Synthesis and conclusions
16. Summary and conclusions
Appendix A
Résumé :
Drug use represents a significant burden to public health through disease, disability and social problems, and policy makers are becoming increasingly interested in how to develop evidence-based drug policy. It is therefore crucial to strengthen the links between addiction science and drug policy. "Drug Policy and the Public Good" is collaboratively written by an international group of career scientists to provide an analytical basis on which to build relevant global drug policies, and to inform policy makers who have direct responsibility for public health and social welfare.
"Drug Policy and the Public Good" presents, in a comprehensive, practical, and readily accessible form, the accumulated scientific knowledge on illicit drugs that has direct relevance to the development of drug policy on local, national, and international levels. The authors describe the conceptual basis for a rational drug policy and present new epidemiological data on the global dimensions of drug misuse. The core of the book is a critical review of the cumulative scientific evidence in five general areas of drug policy: primary prevention programs in schools and other settings; supply reduction approaches, including drug interdiction and legal enforcement; treatment interventions and harm reduction approaches; criminal sanctions and decriminalization; and control of the legal market through prescription drug regimes. The final chapters discuss the current state of drug policy in different parts of the in different parts of the world, and describe the need for a new approach to drug policy that is evidence-based, realistic, and co-ordinated.
The authors describe the conceptual basis for a rational drug policy and present new epidemiological data on the global dimensions of drug misuse. The core of the book is a critical review of the cumulative scientific evidence in five general areas of drug policy: primary prevention programs in schools and other settings; supply reduction approaches, including drug interdiction and legal enforcement; treatment interventions and harm reduction approaches; criminal sanctions and decriminalization; and control of the legal market through prescription drug regimes. The final chapters discuss the current state of drug policy in different parts of the world, and describe the need for a new approach to drug policy that is evidence-based, realistic, and co-ordinated.
By locating drug policy primarily within the realm of public health, this book draws attention to the growing tendency of governments, both national and local, to consider illegal psychoactive substances as a major determinant of ill health, and to organize societal responses accordingly. It will appeal to those involved in both addiction science and drug policy, as well as those in the wider fields of public health, health policy, epidemiology, primary prevention, and treatment services.
"Drug Policy and the Public Good" presents, in a comprehensive, practical, and readily accessible form, the accumulated scientific knowledge on illicit drugs that has direct relevance to the development of drug policy on local, national, and international levels. The authors describe the conceptual basis for a rational drug policy and present new epidemiological data on the global dimensions of drug misuse. The core of the book is a critical review of the cumulative scientific evidence in five general areas of drug policy: primary prevention programs in schools and other settings; supply reduction approaches, including drug interdiction and legal enforcement; treatment interventions and harm reduction approaches; criminal sanctions and decriminalization; and control of the legal market through prescription drug regimes. The final chapters discuss the current state of drug policy in different parts of the in different parts of the world, and describe the need for a new approach to drug policy that is evidence-based, realistic, and co-ordinated.
The authors describe the conceptual basis for a rational drug policy and present new epidemiological data on the global dimensions of drug misuse. The core of the book is a critical review of the cumulative scientific evidence in five general areas of drug policy: primary prevention programs in schools and other settings; supply reduction approaches, including drug interdiction and legal enforcement; treatment interventions and harm reduction approaches; criminal sanctions and decriminalization; and control of the legal market through prescription drug regimes. The final chapters discuss the current state of drug policy in different parts of the world, and describe the need for a new approach to drug policy that is evidence-based, realistic, and co-ordinated.
By locating drug policy primarily within the realm of public health, this book draws attention to the growing tendency of governments, both national and local, to consider illegal psychoactive substances as a major determinant of ill health, and to organize societal responses accordingly. It will appeal to those involved in both addiction science and drug policy, as well as those in the wider fields of public health, health policy, epidemiology, primary prevention, and treatment services.
Affiliation :
USA
- voir aussi :
Cote :
L01935